Connect with us

CBD

Customize Your Cannabinoids – Now You Can Mix’ N’ Match

Most of what’s gone on in the field of medicinal cannabis has been related to simply isolating and/or replicating a specific cannabinoid to get its benefits. In today’s world of cannabis medicine, the new thing is for a customer to order a premium blend of their favorite compounds, because today, you can actually customize your […]

The post Customize Your Cannabinoids – Now You Can Mix’ N’ Match appeared first on CBD Testers.

Republished by Plato

Published

on

Most of what’s gone on in the field of medicinal cannabis has been related to simply isolating and/or replicating a specific cannabinoid to get its benefits. In today’s world of cannabis medicine, the new thing is for a customer to order a premium blend of their favorite compounds, because today, you can actually customize your cannabinoids.

Keep up-to-date in the ever-changing world of medicinal cannabis. Sign up to our newsletter so you never miss a thing!

Isolating cannabinoids

There’s plenty in the worlds of medicinal cannabis and recreational marijuana that have nothing to do with isolating anything. If a person wants to smoke hemp flowers, or buy a few grams of high-THC weed, they’re getting the whole plant, no isolation needed. However, the fields of medical and recreational cannabis have been more and more reliant on the idea of isolated cannabinoids. CBD is the most popular right now, with CBD oil and vape cartridges flying off store shelves all over the world.

Much like with other forms of pharmaceutical medicine, where we often pop a pill without really thinking what that circular, chalky, perfectly-shaped tablet contains, where it came from, and how it got to be in the form we take it in, we don’t often question how our CBD oil came to be.

Cannabinoids don’t start out as cannabinoids, but rather as acids that must be heated – or decarboxylated – in order to form into the cannabinoids we are familiar with like THC, CBD, and even the rarer CGBV, and THCV. Solvents are then used to separate certain parts. These can include, ethanol, hydrocarbon (butane, propane…), chloroform, light petroleum, and CO2 – which doesn’t leave a residue.

short path distillation is used to isolate different compounds using their individual boiling points. A pure powder of a specific cannabinoid is left at the end which can then be used in different ways for different kinds of products. It might not be important to know all the steps of isolating a cannabinoid, but understanding it as a process is important, because this process takes time and money.

Rare cannabinoids

We’re all familiar with THC at this point, as it is the most prevalent cannabinoid of the cannabis plant (for high-THC marijuana). Most of us now know a good bit about CBD too, which also can be found in plentiful amounts, particularly in low-THC hemp.  We also know there are more than 100 cannabinoids in the cannabis plant, even if some of them appear in only trace amounts. The ability to isolate some of these rarer cannabinoids through the process above, gives users that much more choice in terms of products, and the ability to now formulate different mixtures of cannabinoids. Some rarer cannabinoids, and cannabinoid acids, that are now becoming more popular due to the ability to isolate them, are the following:

  • CBG – Cannabigerol – Comes from acidic precursor CBGA and makes up less than 1% of a cannabis plant.
  • CBN – Cannabinol – A phytocannabinoid with THC as a precursor.
  • CBC – Cannabichromene – The second most prevalent cannabinoid in cannabis.
  • CBCA – Cannabichromenic Acid – The acidic precursor to CBC.
  • CBGA – Cannabigerolic Acid – The precursor acid that transforms into acids THCA, CBDA, and CBCA, which in turn produce other cannabinoids.
  • CGBV – cannabigerivarin – A cannabinoid acid with CBG as a precursor.
  • CBNA – Cannabinolic acid – The parent compound that transforms to CBN through decarboxylation.
  • CBCV – Cannabichromevarin – Closely related to CBC, with the difference of a propyl chain.
  • CBDV – Cannabidivarin – Closely related to CBD, and mainly found in cannabis indica landrace strains, generally from Asia and Africa.
  • THCV – Tetrahydrocannabivarin – Similar to THC, and does produce a psychoactive effect.
  • CBDA – Cannabidiolic acid – The precursor to CBD that exists in acid form.
  • THCA – Tetrahydrocannabinolic acid. The precursor to THC that exists in acid form.

And many more, most of which have gotten so little attention as of yet, that there isn’t much written about them, or studies yet performed on them. Whereas major cannabinoids like THC and CBD can take up about 2-20% of a plant’s biomass, these lesser cannabinoids generally make up less than 1%.

own medicinal profile, as they are all unique compounds unto themselves. Sometimes you might want something pure, like CBD oil. Maybe other times you want the whole plant, and the synergistic effect of all parts working together. And on other occasions, you might want to mix and match the different parts and pieces available, to customize your cannabinoids to create medicines very specific to your particular wants and needs.

Mix n match

This new industry of customizing cannabinoids is only just beginning, but it does seem to be taking off. The companies that offer this service are offering a way to create custom medicines, while also introducing customers to lesser known cannabinoids, and cannabinoid acids. The idea of personalized medication is conceptually new to Western medicine. While different people are given different medications to take, in different quantities, pharmaceutical medications are not formulated with a specific person in mind, or tweaked to meet that specific person’s needs. Natural medicine traditions are much more likely to create specialized medication for patients, and this new movement towards the ability to customize your cannabinoids is a mirror of this concept. Instead of the standard ‘trial and error’ in standard medicine, where a person might be cycled through tons of different medications to find something that works specifically with their genetics, the idea is now to tweak the meds to meet the person’s needs.

Companies getting in on it

Global Cannabinoids is a Las Vegas based CBD oil company that now offers something else. CBD oil, and other private label products, that can be customized by the buyer to have an exact profile of cannabinoids – rare and not rare – to meet their needs. This is twofold in that it exposes people to more rare options than the standard CBD, while also giving a level of personalization.

Global Cannabinoids is already one of the biggest white label and private label suppliers of CBD, as well as a leading ingredient supplier for brands that use hemp-derived cannabinoids for their product lines. The company is one of the biggest suppliers for wholesale and bulk cannabinoids, even rarer ones. Customers can purchase CBN, CBC, CBG, and CBDV in the ratios of their choosing. Obviously, there are plenty more rare cannabinoids, as mentioned above, but this opens the door, and gets the ball rolling for using rare cannabinoids at all.

Another company moving in the same direction, is Socati, a company based out of Houston, Texas with a Montana-based facility for manufacturing cannabinoid ingredients, that is known for producing USDA certified organic hemp products. Now, they’re opening up their offering a bit more, just like Global Cannabinoids. Socati recently launched a line of private label products offering the ability to customize your cannabinoids. Custom ratios of CBD, CBG, CBN, and other rare cannabinoids can be made per personal desire in the following products: gummies, tinctures, crystalized flavor powder, pressed tablets, softgels, and capsules.

Precision Plant Molecules is another company now offering a tailored cannabinoid experience. The company is a specialty cannabinoid-based ingredient supplier. It extracts and processes hemp to create distillates, oils, concentrates, extracts, and isolates. While there isn’t much press about the company’s ability to customize your cannabinoid experience, it is explained on their website. PPM uses several minor cannabinoids along with CBD, like: CBN, CBC, CBG, CBT, CBDV, THCV, CBGA, CBDA, and others. According to its website: “Fully customizable ratios of cannabinoids afford more effective health and wellness products. Enriching to achieve a specified ratio of cannabinoids smooths the variability in even Mother Nature’s most stable chemovars.” I expect we’ll be hearing more about this company in the news soon.

The same can be said for Trait, which also hasn’t quite made big news, but which now with Trait Tailored, is also offering customized cannabinoid combinations. According to its website, “Trait Tailored’sTM patent pending technology enables growers to perfectly customize the cannabinoid profiles of their hemp or cannabis strains with ground-breaking precision.” It goes on to say, “With TailoredTM, growers are able to produce strains with greater volumes of CBD, CBG, CBC and other less common cannabinoids to make more refined and desirable products for consumers.”

Conclusion

Customizable medicine is certainly a new thing for most people. As the field of medicinal cannabis grows bigger and bigger, more options are being made available that were never a part of standard Western medicine before. Now, instead of cycling through tons of meds to find the one that works, you can customize your cannabinoids to create the perfect combination for all your health needs.

Thank you for stopping by CBDtesters.co, your hub for all cannabis-related news. Stop by regularly to stay up-to-date, and sign up to our newsletter so you’re always in the loop.

Resources

What are THCV Flowers, and How Are They Different from What You’ve Been Smoking? (Why THCV flowers are unique)
Everything You Need To Know About CBD Isolate (a deep look into hemp extracts)

German Cannabis Flower Market is Ready to Explode
Delta-8 THC Contaminated Products, or Just Bad Press?

Everything You Need To Know About CBG Isolate
Newest Cannabinoid Powerhouse – CBC – What Can It Do for You?
What is DELTA 8 THC (FAQ: Great resource to learn about DELTA 8THC)

Cannabis Cosmetics: What’s Allowed, What’s Not, and Where to Find Them (What is the latest regulations in Europe and which products are allowed)
CBG Study Shows Antimicrobial Properties of Cannabis
The CBD Flowers Weekly newsletter (your top resource for all things smokable hemp flowers)
The Medical Cannabis Weekly newsletter (International medical cannabis business report)
The Legal Landscape Of CBD Hemp Flower In Europe

The Delta 8 Weekly Newsletter (All you need to know about Delta 8 thc)Regulators Go After Smokable Hemp Flower – What Does The Future Hold?
Investing in Delta 8 THC Flowers – Is It The Right Move For Your Business? (All you need to know about the latest hot trend: Delta-8 THC)

Source: https://cbdtesters.co/2020/11/16/customize-your-cannabinoids-now-you-can-mix-n-match/

CBD

CBD News: Clint Eastwood files third suit against CBD companies, saying they’re falsely claiming endorsement

Clint Eastwood has filed a third lawsuit alleging CBD companies are falsely claiming he’s endorsing their products.

Clint Eastwood files third suit against CBD companies, saying they’re falsely claiming endorsement is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs

From Clint Eastwood files third suit against CBD companies, saying they’re falsely claiming endorsement on CBD Products & CBD Business News – Hemp Industry Daily.

This was autoposted by IFTTT. To find out more, read my post about news articles.

Republished by Plato

Published

on

Clint Eastwood has filed a third lawsuit alleging CBD companies are falsely claiming he’s endorsing their products.

Clint Eastwood files third suit against CBD companies, saying they’re falsely claiming endorsement is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs

From Clint Eastwood files third suit against CBD companies, saying they’re falsely claiming endorsement on CBD Products & CBD Business News – Hemp Industry Daily.

This was autoposted by IFTTT. To find out more, read my post about news articles.

Source: http://blog.hempcbd.business/2021/01/cbd-news-clint-eastwood-files-third.html

Continue Reading

CBD

CBD News Roundup: FDA Provides Framework for Future CBD Research

Here’s the latest CBD news: The FDA published a report detailing their plans for data collection and research improvements in the area of CBD research and regulation.  Yale researchers have funded a randomized trial that will measure the effects of CBD on the female brain with a focus on anxiety. A recent survey by University… View Article

The post CBD News Roundup: FDA Provides Framework for Future CBD Research appeared first on The CBD Insider.

Republished by Plato

Published

on

fda to collect better data about cbd

Here’s the latest CBD news:

  • The FDA published a report detailing their plans for data collection and research improvements in the area of CBD research and regulation. 
  • Yale researchers have funded a randomized trial that will measure the effects of CBD on the female brain with a focus on anxiety.
  • A recent survey by University of Michigan researchers explores CBD usage prevalence and habits among fibromyalgia sufferers. 

Table of Contents

  1. FDA Provides Framework for Future CBD Research
  2. Yale Research Group to Explore CBD’s Effects on the Female Brain
  3. Survey Shows CBD’s Popularity Among Fibromyalgia Patients

FDA Provides Framework for Future CBD Research

On January 8, a week before the Senate’s passage of the Cannabidiol and Marijuana Research Expansion Act, the Food and Drug Administration published an overview on their site detailing the current state of their CBD knowledge base as well as a “framework for building a more robust evidentiary foundation” for safer and smarter public use purposes.

The FDA addressed the following items in the report as they relate to their role in the advancement of CBD research and regulation:

  • The 2018 Farm Bill
  • CBD drug approval (epidiolex)
  • Public input on CBD issues from stakeholders
  • FDA-sponsored product sampling and research initiatives
  • Challenges in data collection
  • Unanswered questions

Of particular importance for the continued advancement of CBD research and regulation were the FDAs calls for refinement in “data approaches,” which emphasized an opt-in registry for CBD users, market-research insights, and other data-rich sources that will help assess CBD safety and efficacy more comprehensively.

With the help of the Cannabidiol and Marijuana Research Expansion Act, which is designed to support and streamline the CBD data-collection infrastructure, the FDA seeks to define the CBD “safety profile” more completely for consumer education and regulation purposes.

Yale Research Group to Explore CBD’s Effects on the Female Brain

A team of psychology experts from Women’s Health Research at Yale (WHRY) led by Assistant Professor of Psychiatry Dr. Sarah Lichenstein announced on January 11th that their department has funded a randomized, double-blind, placebo-controlled study to examine the effects of CBD on the female brain.

Aiming to expand on the sparse number of findings related to gender-specific effects of CBD, the study will use functional MRI technology to assess activity levels in stress centers of the brain after CBD is administered to participants.

The Yale announcement cites known discrepancies in anxiety prevalence across genders—women are affected twice as often as men—and safety concerns related to benzodiazepine use as key motivators driving this vein of CBD research.

According to WHRY Director Carol M. Mazure, Ph.D., “Dr. Liechtenstein’s study will help us to understand the mechanisms underlying CBD and whether it has therapeutic potential for anxiety.”

Much of the gender-specific research that has been conducted on CBD was summarized in a 4-panel meeting held by the FDA in November of last year, which provided similar insights into the greater prevalence of anxiety and anxiety medication use in women. 

Survey Shows CBD’s Popularity Among Fibromyalgia Patients

The results of a survey published in the Journal of Pain on January 2 by University of Michigan Medical School experts found that almost two-thirds of surveyed fibromyalgia patients are using or have used CBD products.

Survey data revealed that 29.4% of the 2,701 respondents used CBD in the past, and 32.4% were using it at the time, totaling 61.8%.

Researchers also assessed several important dimensions related to the perception and use of CBD by fibromyalgia patients, including: 

  • Reasons for use and discontinuation
  • Communication with healthcare professionals about CBD
  • Perceptions of CBD effectiveness and safety

Most of the respondents used CBD to address “inadequate symptom relief,” and two-thirds of CBD users disclosed their use to their physicians. 

Finally, respondents reported mild to moderate improvements across multiple symptoms. 

Authors called for more studies to further devine CBD’s treatment potential and safety for this population and other chronic pain sufferers. 

The CBD Insider Editorial Team

The mission of The CBD Insider is to provide consumers with a way to find high-quality, safe, and well-formulated CBD products. Our editorial team of passionate industry professionals achieves this mission by providing unbiased, trustworthy, and well-researched reporting about the CBD industry.

Source: https://thecbdinsider.com/news/cbd-news-roundup-fda-provides-framework-for-future-cbd-research/

Continue Reading

CBD

CBD News: Illinois sees more hemp processors but fewer acres as industry matures in agricultural powerhouse

The number of hemp processors in Illinois doubled over the last year as the new industry tries to establish itself in a state that’s already an agricultural powerhouse.

Illinois sees more hemp processors but fewer acres as industry matures in agricultural powerhouse is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs

From Illinois sees more hemp processors but fewer acres as industry matures in agricultural powerhouse on CBD Products & CBD Business News – Hemp Industry Daily.

This was autoposted by IFTTT. To find out more, read my post about news articles.

Republished by Plato

Published

on

The number of hemp processors in Illinois doubled over the last year as the new industry tries to establish itself in a state that’s already an agricultural powerhouse.

Illinois sees more hemp processors but fewer acres as industry matures in agricultural powerhouse is a post from: Hemp Industry Daily: Financial, Legal & business news for hemp & CBD entrepreneurs

From Illinois sees more hemp processors but fewer acres as industry matures in agricultural powerhouse on CBD Products & CBD Business News – Hemp Industry Daily.

This was autoposted by IFTTT. To find out more, read my post about news articles.

Source: http://blog.hempcbd.business/2021/01/cbd-news-illinois-sees-more-hemp.html

Continue Reading
News4 days ago

Pure Harvest Bolsters Corporate Team with Key Additions

Heartland5 days ago

Mydecine Innovations Group Appoints Gordon Neal to Board of Directors and Dean Ditto as Chief Financial Officer

Heartland5 days ago

Cannabis Heroes of History: How Robert Randall Beat the U.S.

Heartland4 days ago

High Times Greats: John Carpenter

Heartland5 days ago

Cannabis Sales Hit $427 Million During The Holidays

Uncategorized5 days ago

Elixinol CBD Gummies Review

Heartland5 days ago

Wilfred Creator Jason Gann On Pivoting Into The Cannabis Market

Uncategorized2 days ago

MediPharm Labs Appoints Warren Everitt, CEO Australia Pacific, to Board of Directors

News5 days ago

Survey Finds Majority of Americans View Cannabis As Less Harmful Than Alcohol

Heartland5 days ago

Barney’s Farm Promo – Win a 5 Pack – 4 Prizes

Heartland5 days ago

PharmaDrug Announces LOI to Acquire Sairiyo Therapeutics Inc.

Heartland5 days ago

Top Reasons Why CBD Might Not Work for You

Heartland4 days ago

Freeway Rick Ross: No longer the Face of a “Convict” but the face of two Million dollar Marijuana brands….

Heartland5 days ago

Is smokable hemp flower in trouble?

News5 days ago

Mississippi Now Has Timeline For Medical Marijuana Rollout

CBD5 days ago

CBD News: New industry group in Spain aims to change government’s flower opposition

Uncategorized1 day ago

New York Small Business Cooperative License

Heartland5 days ago

Organigram Stock Falls As Company Warns About Second Quarter

Uncategorized3 days ago

Truss CBD USA Is Hexo’s Official Entry Point Into The U.S. Market

Heartland5 days ago

Charlotte’s Web Secures U.S. Utility Patents for Two New Hemp Varietals with Superior Cannabinoid Expression

Heartland3 days ago

MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience

Heartland5 days ago

Smoking CBD flower? CBD pre-rolls could become the next big thing (especially if you want to quit smoking)

Heartland3 days ago

Argentina Allows Cannabis Self-Cultivation

Heartland5 days ago

Champignon Brands Announces New CFO and New General Counsel

Heartland5 days ago

Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics

Heartland4 days ago

Vext Science Raises C$18 Million Selling Units at C$1.12

Heartland5 days ago

NeonMind Engages Dr. C. Laird Birmingham to Develop Protocols for Phase 2 Clinical Trial Using Psilocybin to Treat Obesity

Heartland5 days ago

NeonMind Announces Grants Pursuant to Stock Option Plan

Uncategorized1 day ago

New York Cannabis Distributor License

Heartland20 hours ago

30 Best Stoner Coloring Books on Amazon

Trending

A Cloud Nine Capital Entity Copyright © 2020 – All Rights Reserved Proudly Made in America